The U.S. Federal Trade Commission (FTC) has reached a settlement with marketers i-Health, Inc. and Martek Biosciences in a case accusing the companies of falsely advertising their BrainStrong Adult supplement as preventing cognitive decline and improving memory without clinical proof to support their claims. In re i-Health, Inc., No. C-4486 (FTC, order issued August 21, 2014). The order prevents i-Health and Martek from using these representations without competent and reliable scientific evidence; more generally, it also prohibits the marketers from making other health claims about BrainStrong Adult without scientific evidence or misrepresenting the results of any study in their advertising. In addition, the marketers must maintain a collection of all promotional materials for the product and all research related to it for five years, and the order will remain in force for 20 years.